Characterizing the Bone Marrow Environment in Advanced-Stage Myelofibrosis during Ruxolitinib Treatment Using PET/CT and MRI: A Pilot Study

Current diagnostic criteria for myelofibrosis are largely based on bone marrow (BM) biopsy results. However, these have several limitations, including sampling errors. Explorative studies have indicated that imaging might form an alternative for the evaluation of disease activity, but the heterogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Slot, Stefanie, Lavini, Cristina, Zwezerijnen, Gerben J. C., Boden, Bouke J. H., Marcus, J. Tim, Huisman, Marc C., Yaqub, Maqsood, Barbé, Ellis, Wondergem, Mariëlle J., Zijlstra, Josée M., Zweegman, Sonja, Raijmakers, Pieter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037592/
https://www.ncbi.nlm.nih.gov/pubmed/36960997
http://dx.doi.org/10.3390/tomography9020038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037592/
https://www.ncbi.nlm.nih.gov/pubmed/36960997
http://dx.doi.org/10.3390/tomography9020038

Ejemplares similares